JULIANN ROMASCO: Open Payments
NPI 1073728986 · CHARLEROI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 130 payments from 23 companies in 2025. Trend: 2023 $1,977 · 2024 $2,228 · 2025 $2,178
Food & beverage: $2,178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $343 |
| PFIZER INC. | 19 | $306 |
| GlaxoSmithKline, LLC. | 16 | $255 |
| AstraZeneca Pharmaceuticals LP | 7 | $212 |
| Novo Nordisk Inc | 12 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $114 |
| Exact Sciences Corporation | 5 | $92 |
| Amgen Inc. | 5 | $88 |
| Lilly USA, LLC | 5 | $83 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
Products named: TRELEGY ELLIPTA, ELIQUIS, BREZTRI, Kerendia, OTEZLA, QULIPTA, MOUNJARO, FARXIGA.
Industry payments across PA — which companies pay providers there.
